<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">Employment of known G4 ligands has provided interesting insights in the regulation of HSV-1 G4s, first and foremost the reduction in virus replication, obtained after treatment with either BRACO-19 (IC
 <sub>50</sub>  ~ 8 μM)
 <xref rid="bb0080" ref-type="bibr">
  <sup>15</sup>
 </xref> or a core-extended naphthalene diimide derivative (IC
 <sub>50</sub>  ~ 18 nM).
 <xref rid="bb0100" ref-type="bibr">
  <sup>19</sup>
 </xref> Both compounds led to a significant reduction in viral DNA synthesis and late transcripts production. Furthermore, 
 <italic>in vitro</italic> assays revealed the ability of G4 ligands to improve further HSV-1 G4s stability and their ability to stall polymerase progression.
</p>
